title: Radiopharmaceutical considerations for using Tc-99m MAA in lung transplant patients.
abstract: OBJECTIVE
  To elucidate radiopharmaceutical considerations for using technetium Tc-99m albumin aggregated (Tc-99m MAA) in lung transplant patients and to establish an appropriate routine dose and preparation procedure.
  
  
  METHODS
  Tertiary care academic hospital during May 2007 to May 2009.
  
  
  METHODS
  Nuclear pharmacist working in nuclear medicine department.
  
  
  METHODS
  Radiopharmaceutical considerations deemed important for the use of Tc-99m MAA in lung transplant patients included radioactivity dose, particulate dose, rate of the radiolabeling reaction (preparation time), and final radiochemical purity. Evaluation of our initial 12-month experience, published literature, and professional practice guidelines provided the basis for establishing an appropriate dose and preparation procedure of Tc-99m MAA for use in lung transplant patients.
  
  
  METHODS
  Radiochemical purity at typical incubation times and image quality in subsequent lung transplant patients imaged during the next 12 months.
  
  
  RESULTS
  Based on considerations of radioactivity dose, particulate dose, rate of the radiolabeling reaction (preparation time), and final radiochemical purity, a routine dose consisting of 3 mCi (111 MBq) and 100,000 particles of Tc-99m MAA for planar perfusion lung imaging of adult lung transplant patients was established as reasonable and appropriate. MAA kits were prepared with a more reasonable amount of Tc-99m and yielded high radiochemical purity values in typical incubation times. Images have continued to be of high diagnostic quality.
  
  
  CONCLUSIONS
  Tc-99m MAA used for lung transplant imaging can be readily prepared with high radiochemical purity to provide a dose of 3 mCi (111 GBq)/100,000 particles, which provides images of high diagnostic quality.
authors.affiliation: Division of Nuclear Medicine, University of Iowa Hospitals and Clinics, 200 Hawkins Dr., Iowa City, IA 52242, USA. james-ponto@uiowa.edu
authors.forename: James A
authors.initials: JA
authors.lastname: Ponto
mesh_terms: D000046:Academic Medical Centers; D004339:Drug Compounding; D006801:Humans; D016040:Lung Transplantation / Q000000981:diagnostic imaging*; D011829:Radiation Dosage; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals; D013668:Technetium Tc 99m Aggregated Albumin
chemical_list: D019275:Radiopharmaceuticals; D013668:Technetium Tc 99m Aggregated Albumin